FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3 letters match. Newest first.

  1. Verdure Sciences, Inc.

    FDA says Verdure Sciences ran a clinical trial of Maplifa without submitting a required IND.

    High risk
  2. ISOThrive, Inc.

    ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.

    High risk
  3. Tyrone L. McCall, M.D./Cornea Associates of Texas

    FDA warns Dallas eye practice Cornea Associates for running a 69-subject drug study without an IND.

    High risk